Department of Breast and Endocrine Surgery, Osaka University, Graduate School of Medicine, Suita City, Japan.
Department of Breast and Endocrine Surgery, Osaka University, Graduate School of Medicine, Suita City, Japan.
Am J Pathol. 2018 May;188(5):1106-1112. doi: 10.1016/j.ajpath.2018.01.005. Epub 2018 Feb 16.
The pathologic feature of intraductal papillomas is defined as a papillary structure composed of a fibrovascular stromal core lined by luminal epithelial cells and myoepithelial cells. We used droplet digital PCR for the mutational analysis of AKT1 (E17K) and PIK3CA (H1047R, E542K, and E545K) in 60 papillomas. AKT1 and PIK3CA mutations were detected in 12 (20%) and 17 (28%) of the papillomas, respectively. In five tumors harboring mutations, mutational analysis of AKT1 or PIK3CA was performed separately using luminal epithelial cells and myoepithelial cells sorted using anti-cytokeratin 19 antibody and anti-α smooth muscle actin antibody. The two types of cells from a given papilloma had the identical mutation. Three patients with the PIK3CA mutation-positive papilloma developed breast cancers at the resection site of the papilloma, but none of these subsequent breast cancers had the PIK3CA mutation. These results indicate that a papilloma stems from a bipotent progenitor cell that contains the AKT1 or PIK3CA mutation and proliferates and differentiates to form the papilloma. Papilloma can be a risk factor for developing breast cancer but is unlikely to be its obligate precursor.
导管内乳头状瘤的病理特征定义为一种乳头状结构,由富含纤维血管的基质核心组成,内衬有腔上皮细胞和肌上皮细胞。我们使用液滴数字 PCR 对 60 个乳头状瘤中的 AKT1(E17K)和 PIK3CA(H1047R、E542K 和 E545K)的突变进行了分析。在 12 个(20%)和 17 个(28%)乳头状瘤中分别检测到 AKT1 和 PIK3CA 突变。在 5 个携带突变的肿瘤中,使用抗细胞角蛋白 19 抗体和抗α平滑肌肌动蛋白抗体分别对 AKT1 或 PIK3CA 进行突变分析,对分离出的腔上皮细胞和肌上皮细胞进行分析。给定的乳头状瘤的两种类型的细胞具有相同的突变。3 名患有 PIK3CA 突变阳性的乳头状瘤的患者在乳头状瘤的切除部位发生了乳腺癌,但这些后续的乳腺癌均无 PIK3CA 突变。这些结果表明,乳头状瘤起源于含有 AKT1 或 PIK3CA 突变的双能祖细胞,该祖细胞增殖并分化形成乳头状瘤。乳头状瘤可能是发生乳腺癌的危险因素,但不太可能是其必需的前体。